skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines enfortumab vedotinQuestion & answer

enfortumab vedotin · Medicine question

Which cell-surface protein does enfortumab vedotin target?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Enfortumab vedotin targets Nectin-4, an adhesion protein located on the surface of urothelial cancer cells.

Sources for this answer

Padcev 20 mg and 30 mg powder for concentrate for solution for infusionAstellas Pharma Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 10Document updated 5 May 2026

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

More questions about enfortumab vedotin

Can enfortumab vedotin cause hair loss?How long should women of reproductive potential use effective contraception after stopping enfortumab vedotin?What eye problems have been reported with enfortumab vedotin?What injury can occur if enfortumab vedotin leaks outside the vein during infusion?What is the enfortumab vedotin concentration in Padcev after reconstitution?What monitoring is recommended when enfortumab vedotin is given with clarithromycin?

enfortumab vedotin

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the enfortumab vedotin guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX